Thiol PEG NHS, HS-PEG-NHS - MW 5000 Da

Cat. No.: T164374
Disponibile su ordine
QUALITÀ & PUREZZA MW 5000 Da
Storage
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
T164374-100mg
—
1 Disponibile

124,87€

147,43€
Salva 22,56 € (15.30%)
500mg
T164374-500mg
—
1 Disponibile

321,84€

507,54€
Salva 185,70 € (36.59%)
Enter a quantity for the sizes you want to add.

Panoramica

Heterobifunctional PEG derivative that can be used to modify proteins, peptides and other materials via amino or other acid reactive chemical groups. PEGylation can increase solubility and stability and reduce immunogenicity of peptides and proteins. It can also suppress the non-specific binding of charged molecules to the modified surfaces. .

Specifiche

Specifiche e purezza
MW 5000 Da
Condizioni di conservazione di stoccaggio
Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDataOggetto
C23201164C23201164Certificate of AnalysisApr 03, 2026 T164374
C23201165C23201165Certificate of AnalysisApr 03, 2026 T164374
C23201166C23201166Certificate of AnalysisApr 03, 2026 T164374
C23201173C23201173Certificate of AnalysisApr 03, 2026 T164374
Proprietà chimiche e fisiche
SolubilitàOff-white/white solid or viscous liquid depends on molecule weight;Soluble in regular aqeous solution as well as most organic solvents;
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

The following are general, literature-based protocols for using HS-PEG-NHS in bioconjugation. They are not item-specific specifications; optimize for your system.

Protocol A: Amine-first, then thiol coupling

  1. Prepare buffers: 50 mM phosphate, pH 7.4–7.8 (no primary amines). Chill to 4–8°C if working with labile proteins.
  2. Make a fresh HS-PEG-NHS stock at 10–50 mM in anhydrous DMSO under argon. Use within 30–60 minutes.
  3. Add stock dropwise to the protein/amine solution (0.1–10 mg/mL), targeting 2–10 molar equivalents per accessible amine. Incubate 30–90 min at 4–25°C.
  4. Quench residual NHS with 10–50 mM ethanolamine (optional). Purify by SEC or ultrafiltration (MWCO chosen per PEG MW and protein size).
  5. For thiol coupling to a maleimide partner, buffer-exchange into 50 mM phosphate or HEPES, pH 6.8–7.2. Add maleimide reagent (1.2–3 eq) and incubate 30–60 min at RT. Remove excess by SEC/UF.

Protocol B: Surface modification

  1. Functionalize surface with primary amines (e.g., APTES on oxides). Rinse and equilibrate in phosphate buffer, pH ~8.0.
  2. Apply HS-PEG-NHS from DMSO stock diluted into buffer to 0.5–5 mM. React 1 h at RT.
  3. Rinse, then couple the terminal thiol to maleimide-activated ligand or to gold surfaces under inert atmosphere.

Quality control: Verify conjugation by Ellman’s assay (for residual free thiols), ninhydrin or TNBS (for free amines), SEC profiles, and mass spectrometry where applicable.

Biological Roles

This reagent is a synthetic conjugation tool; it does not possess intrinsic biological activity in the sense of a metabolite or ligand. The PEG backbone is widely regarded as biologically inert and hydrophilic, providing spacing and steric shielding in biomolecular assemblies.

General/literature context:

  • PEGylation effects:
    • Reduces protein surface fouling and nonspecific adsorption by creating a hydration shell.
    • Can modulate colloidal stability of nanoparticles and liposomes by steric repulsion.
  • Reactivity toward biomolecules:
    • NHS ester selectively acylates accessible primary amines on proteins/peptides under mild conditions without needing catalysts.
    • The thiol end can engage in biorthogonal pairing to maleimide groups on biomolecules or materials.
  • Structural/biochemical implications:
    • The flexible PEG spacer increases effective reach between conjugation partners and can reduce steric hindrance, often improving activity retention of enzymes or antibodies in immobilized formats.
    • Chain length tunes hydrodynamic size and spacing; longer PEGs increase water layer thickness but may decrease packing density on surfaces.

Note: All uses are for research and laboratory applications only. No claims are made for therapeutic, diagnostic, or clinical deployment of this product.

Buffer Applications

HS-PEG-NHS is commonly used in buffered aqueous systems for bioconjugation. Buffer choice strongly affects NHS stability and thiol chemistry.

  • For NHS–amine coupling (general/literature):
    • Preferred buffers: PBS (phosphate-buffered saline), sodium phosphate (10–100 mM), bicarbonate/carbonate; avoid primary amines (e.g., Tris, glycine).
    • pH window: 7.2–8.5. Higher pH increases rate but accelerates hydrolysis; pH ~7.4–8.0 often balances performance.
    • Ionic strength: 0.1–0.3 M NaCl helps maintain protein stability and reduces nonspecific interactions.
  • For thiol coupling (to maleimide/haloacetamide):
    • Buffers: Phosphate or HEPES, 10–100 mM, pH 6.5–7.5 (maleimide optimal near pH 6.8–7.2 to limit maleimide hydrolysis).
    • Reducing agents: Use TCEP judiciously to generate free thiols on targets; do not include thiol reductants during the NHS coupling step.
  • Practical preparation:
    • Prepare HS-PEG-NHS as a fresh, anhydrous DMSO stock (e.g., 10–50 mM) and dilute into buffer immediately before use.
    • Degas buffers for thiol preservation; filter-sterilize if working with proteins.

Note: Buffer recipes and concentrations should be optimized for the specific biomolecule or surface; confirm compatibility empirically.

Green Alternatives

PEG-based heterobifunctional linkers already offer certain environmental advantages (aqueous compatibility, low volatility). Still, greener choices can be made in solvent and process design.

  • Greener solvent options (general):
    • Prefer water or buffered aqueous media when compatible with target stability; use minimal anhydrous DMSO as a cosolvent for NHS delivery.
    • Replace DMF/DMAc with glycerol carbonate or propylene carbonate in purely synthetic settings when feasible (literature emerging; check solubility/reactivity).
    • Ethyl lactate can act as a greener organic co-solvent for some PEG linkers; verify NHS stability.
  • Process intensification:
    • Perform reactions at ambient temperature and near-neutral pH to reduce energy demand and limit hydrolysis waste.
    • Use micro- or flow-addition of concentrated stocks to minimize NHS exposure to bulk water.
  • Alternative chemistries:
    • Enzymatic ligations (e.g., sortase, transglutaminase) are greener but require specific recognition motifs and are not direct substitutes for NHS/thiol.
    • Click-type conjugations (SPAAC) avoid catalysts/solvents but need specialized reagents.

Comparison (general)

  • Approach: Aqueous PBS/HEPES with DMSO stock vs DMF bulk solvent
  • Advantages: Lower toxicity, easier waste handling vs higher NHS lifetime in strictly anhydrous media
  • Trade-offs: Slightly higher hydrolysis risk in aqueous systems, mitigated by just-in-time dilution and lower temperatures.
Pharmaceutical Uses

No pharmacopeial status, excipient listing, or clinical usage is specified for this item. The following are general research/formulation-context notes for heterobifunctional PEG linkers.

  • Role in development workflows (general):
    • Used to prepare PEGylated proteins, peptides, and surfaces during discovery-stage screening to improve stability, solubility, and reduce nonspecific interactions.
    • Enables attachment of targeting ligands or payloads to carrier systems (e.g., nanoparticles) via orthogonal handles.
  • Manufacturing/formulation considerations:
    • End-group integrity (NHS activity, free –SH content) and average MW must be tightly controlled; lot-specific CoAs are typically required.
    • Residual solvents (DMSO/DMF) and hydrolysis byproducts (NHS, acids) should be minimized and controlled via appropriate purification.
    • For regulated applications, alternative linkers with compendial monographs may be preferred; PEG base polymers can be compendial, but specific functionalized PEGs typically are not.
  • Stability and packaging:
    • Supplied under inert gas in moisture-barrier containers to preserve NHS activity and thiol functionality.

All references here are for research and process development context only; no therapeutic or clinical claims are made for this product.

Physical Properties

Item-specific physical constants are not provided for this SKU and can vary with PEG chain length.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet. (PEG reagents are typically provided with an average MW.)
  • Solubility (general/literature):
    • Highly soluble in polar aprotic solvents (DMSO, DMF, DMAc) and compatible with mixed aqueous/organic systems.
    • Water solubility increases with PEG length; most HS-PEG-NHS variants are at least moderately water-dispersible. Solubility can be enhanced by brief sonication and gentle warming.
  • State: Solid or viscous semi-solid depending on MW (literature/general).
  • Density, refractive index, logP, pKa: Not specified for this item; refer to CoA/Spec Sheet. (NHS ester hydrolyzes in water; thiol pKa typically ~8–10 in aliphatic thiols, literature/general.)
  • Stability considerations (general/literature):
    • NHS esters hydrolyze in aqueous media; half-life depends on pH and temperature (shorter at higher pH and higher temperature).
    • Thiol end-group is air/oxygen sensitive and can oxidize to disulfides; inert-atmosphere handling is beneficial.

Because PEG linkers are polydisperse, melting point and viscosity range broadly and depend on average MW; consult the specific CoA for numeric specifications if required.

Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Context for PEG bioconjugation reagents (general/literature):

  • Typical quality designations for HS-PEG-NHS include “bioconjugation grade” or “>95% functionalization,” often accompanied by analysis of residual solvents, succinimide content, and end-group substitution levels. When provided, the MW is an average (Mn or Mw) with polydispersity index (Ð).
  • Functional end-groups:
    • NHS activity is frequently qualified by hydrolysis testing and amine-reactivity assays; stability is moisture- and temperature-dependent.
    • Thiol content may be confirmed by Ellman’s reagent (DTNB) or NMR integration against internal standards.
  • Stabilizers: If present in other products, stabilizers or desiccants help limit NHS hydrolysis and thiol oxidation; none are specified for this item.
  • Documentation to request when qualifying material:
    • CoA listing average MW, substitution level, residual solvent, and water content.
    • End-group integrity (NHS/thiol) and bioburden/endotoxin if for sensitive biological workflows (not specified for this item).

Note: In the absence of stated grade, users should validate performance in their intended application (e.g., small-scale test couplings) and consult the SDS/CoA for lot-specific attributes.

Reaction and Applications

HS-PEG-NHS is a versatile heterobifunctional crosslinker for orthogonal bioconjugation and surface modification.

  • Primary amine coupling (NHS ester):
    • Rapidly acylates lysine side chains or N-termini on proteins/peptides and amine-functionalized surfaces. Optimal at pH 7.2–8.5 in non-amine buffers.
    • Hydrolysis competes with amine coupling; minimize by using fresh solutions, low temperature, and timely addition.
  • Thiol conjugation (terminal –SH):
    • Subsequent reaction with maleimides (Michael addition) at pH 6.5–7.5 yields stable thioether linkages.
    • Alternative routes: disulfide exchange with activated disulfides, Au–S chemisorption on gold surfaces, or alkylation by haloacetamides.
  • Applications (general/literature):
    • Protein–surface PEGylation to reduce fouling and nonspecific adsorption.
    • Creation of antibody–surface or enzyme–nanoparticle conjugates with controlled orientation using orthogonal handles.
    • Fabrication of biosensors and passivated interfaces; spacing and hydration layer provided by PEG enhances stability.
    • Polymer and hydrogel crosslinking when combined with complementary thiol- or amine-bearing polymers.
  • Practical tips:
    • Sequence the reactions to protect sensitive functionalities: often NHS-first to amines, then thiol coupling (introduce reducing agent like TCEP only after NHS reaction step; avoid DTT during NHS steps).
    • Degas buffers and maintain inert atmosphere to preserve thiol.
    • Use slight molar excesses (1.2–5×) depending on target density and desired substitution level; optimize empirically.
Reaction Conditions

Typical conditions below are general literature guidance for heterobifunctional NHS/thiol PEG linkers; adjust to target system and scale.

  • NHS–amine coupling:
    • Solvent/buffer: PBS or 50–100 mM phosphate, pH 7.4–8.2; avoid amine buffers. Use fresh anhydrous DMSO stock of HS-PEG-NHS (e.g., 10–50 mM) and add to the buffered amine solution with mixing.
    • Temperature/time: 0–25°C for 30 min to 2 h. Lower temperatures and shorter times reduce hydrolysis for sensitive targets.
    • Stoichiometry: 1.2–10 equivalents vs accessible amine, depending on desired substitution.
    • Quench/unreacted removal: Quench with ethanolamine or hydroxylamine if needed, then purify by SEC, dialysis, or ultrafiltration.
  • Thiol coupling (to maleimide):
    • Buffer: 50 mM phosphate or HEPES, pH 6.8–7.2, degassed.
    • Temperature/time: 0–25°C for 30 min to 2 h; reactions are typically rapid at room temperature.
    • Reducing environment: Use TCEP (0.1–1 mM) only to maintain target thiols; avoid competing thiols (e.g., DTT) that consume maleimide. Do not include reductants during the NHS step.
  • Notes on kinetics (general):
    • NHS ester half-life shortens markedly above pH 8; prepare immediately prior to use.
    • Thiol oxidation to disulfide can occur within hours in air; keep under inert gas and minimize delays.

All values are literature/general guidance and not item specifications.

Safety and Handling

Safety classifications for this specific item are not provided in the supplied data.

  • GHS classification, pictograms, H-statements, signal word: Not specified for this item; refer to SDS.

General/literature-based handling guidance for NHS esters and thiols:

  • Hazards and sensitivities:
    • NHS esters are moisture sensitive; hydrolysis yields the non-reactive acid and NHS. Avoid humidity to preserve activity.
    • Thiols can oxidize to disulfides and may have a characteristic odor; some thiols can cause skin/eye irritation.
  • PPE: Wear suitable laboratory PPE including lab coat, safety glasses or goggles, and chemical-resistant gloves (e.g., nitrile). Use in a fume hood when weighing or preparing solutions.
  • Storage incompatibilities:
    • Avoid bases, nucleophiles (e.g., primary amines such as Tris) and aqueous buffers during storage; they promote NHS ester hydrolysis.
    • Avoid oxidants and air exposure that could oxidize the thiol to disulfide.
  • First-aid overview (general):
    • Skin/eye contact: Rinse with plenty of water for at least 15 minutes; remove contaminated clothing; seek medical attention as needed.
    • Inhalation: Move to fresh air; obtain medical attention if symptoms persist.
    • Ingestion: Rinse mouth; seek medical advice.
  • Fire and thermal decomposition: Combustible organic polymer; use standard extinguishing media (CO2, dry chemical, foam). Thermal decomposition may produce CO/CO2 and nitrogen oxides.

Always consult the product-specific SDS for authoritative safety and regulatory guidance.

Solvent Selection

HS-PEG-NHS dissolves readily in polar aprotic media; aqueous compatibility depends on MW and use-case.

  • Polarity class (general): Highly polar, hydrogen-bond accepting polymer due to PEG ether oxygens; end-groups confer reactivity rather than bulk solvation behavior.
  • Recommended solvents (general/literature):
    • Anhydrous DMSO or DMF for stock solutions and immediate use in bioconjugation.
    • For aqueous reactions, prepare a concentrated anhydrous DMSO/DMF stock and dilute into buffer immediately before use to limit NHS hydrolysis.
  • Buffer compatibility (for NHS reactions):
    • Use non-amine buffers (PBS, phosphate, bicarbonate, HEPES). Avoid Tris, glycine, or other primary amines that quench NHS esters.
    • pH 7.2–8.5 balances reactivity vs hydrolysis.
  • Thiol end-group considerations:
    • Keep solutions deoxygenated (argon- or nitrogen-sparged) to minimize disulfide formation.
    • For subsequent thiol coupling (e.g., to maleimide), run near-neutral pH in phosphate/HEPES. Avoid strong bases and metal contaminants that promote oxidation.

Comparison (general):

  • DMSO vs DMF: DMSO is more benign and water-miscible; DMF may better solubilize some hydrophobic targets but poses toxicity/regulatory burdens.
  • Water-only systems are possible for longer PEGs but increase NHS hydrolysis; mixed organic/aqueous is typically optimal.
Storage and Reconstitution
  • Storage conditions (item-specific): Store at -20°C, Argon charged.
  • Shipped in (item-specific): Ice chest + Ice pads.

General guidance for this reagent class:

  • Container: Keep tightly sealed in moisture-barrier vials with desiccant. Minimize headspace oxygen to protect the thiol.
  • Light and moisture: Protect from light and humidity. Allow containers to equilibrate to room temperature before opening to avoid condensation.
  • Reconstitution:
    • Use anhydrous solvents (DMSO or DMF) under inert atmosphere to prepare concentrated stocks (e.g., 10–50 mM). Mix gently until fully dissolved.
    • Filter through 0.2 µm if needed for sterile workflows; work quickly to limit NHS hydrolysis.
  • Aliquoting and working solutions:
    • Prepare single-use aliquots; avoid repeated freeze–thaw cycles that accelerate hydrolysis and thiol oxidation.
    • Short-term storage of aliquots at -20°C under argon is acceptable; long-term stability depends on MW and packaging—monitor by test reactions.
  • Incompatibilities during storage: Do not store in aqueous or amine-containing buffers; avoid exposure to oxidants or metal ions that catalyze thiol oxidation.

Always refer to the product’s CoA/Spec Sheet and SDS for lot-specific guidance on stability, reconstitution limits, and safe handling.

Structure and Identity

HS-PEG-NHS is a heterobifunctional polyethylene glycol (PEG) linker bearing a terminal thiol (–SH) on one end and an N-hydroxysuccinimide (NHS) activated ester on the other. This enables orthogonal coupling to primary amines (via NHS-ester acylation) and to thiols or thiol-reactive handles (via the terminal –SH).

  • Item-specific identifiers:

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet. Note: PEG products are often polydisperse; MW is typically an average (Mn or Mw) when provided.
    • SMILES / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature description):

    • Backbone: Repeating –CH2–CH2–O– units (polyethylene glycol).
    • End-group A: Terminal thiol (–SH), typically presented as –(CH2)n–SH or directly attached to PEG.
    • End-group B: NHS-activated carboxylate ester (succinimide leaving group) for rapid acylation of primary amines.
    • 2D description in words: A flexible, hydrophilic PEG chain connects two orthogonal reactive termini; one end is an NHS succinimide ring attached through a carbonate/ester linkage to PEG, the other is a free thiol. No defined stereocenters on the PEG chain; the succinimide ring is planar.
  • Category: Heterobifunctional PEG crosslinker/bioconjugation reagent.

  • Note on identity: Specific spacer lengths (PEG repeat count) and linker architectures vary by catalog variant; consult the product’s CoA for exact average chain length and functional end-group spacing.

Synthetic Utility

Functionally, HS-PEG-NHS provides a hydrophilic, flexible spacer that bridges nucleophilic amines and thiol-reactive partners, enabling modular assembly under mild conditions.

  • Key functional groups and reactivity:
    • NHS ester: Activated carboxylate that undergoes rapid acyl substitution with primary amines to form stable amide bonds; susceptible to hydrolysis.
    • Thiol: Engages in Michael addition to maleimides (forming non-reversible thioethers), disulfide exchange, and soft–soft interactions with gold surfaces.
  • Utility in synthesis and materials:
    • Surface modification: Introduce amine-reactive or thiol-presenting PEG layers on inorganic/organic substrates, improving wettability and antifouling.
    • Polymer chemistry: Crosslink or end-functionalize polymers containing amine or maleimide/haloacetamide groups to form hydrogels or block copolymers.
    • Bioconjugation: Site-flexible attachment to lysine residues, followed by site-targeted thiol reactions for orientational control.
  • Retrosynthetic value:
    • Enables decoupling of amine selection (first step) from thiol chemistry (second step), providing orthogonal routes to complex constructs without protecting groups.
  • Practical notes:
    • Conduct NHS couplings at near-neutral to mildly basic pH; perform thiol reactions soon after deprotection to avoid oxidation.
    • Excess reagent and byproducts can be removed by dialysis, spin filtration (MWCO selection based on PEG MW), or chromatographic methods.
Target Specificity

Not applicable. This product is a chemical conjugation reagent and does not possess antigen/epitope specificity, clone identity, or species reactivity. For biological targeting, specificity arises from the biomolecule or ligand you attach using HS-PEG-NHS. Refer to Reaction & Applications and Synthetic Utility for guidance on pairing with amine- or thiol-bearing targets.

Domande frequenti

How should this product be stored?
Store at ?20 °C under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.